Morgan Stanley Io Biotech, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Io Biotech, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,202,085 shares of IOBT stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,202,085

Previous 1,972,343 11.65%

Holding current value

$2.07 Million

Previous $2.31 Million 0.22%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.75 - $1.64 $172,306 - $376,776	229,742 Added 11.65%	2,202,085 $2.31 Million
Q2 2024 Oct 17, 2024	SELL	$1.17 - $1.71 $263,122 - $384,563	-224,891 Reduced 10.24%	1,972,343 $2.31 Million
Q2 2024 Aug 14, 2024	SELL	$1.17 - $1.71 $263,122 - $384,563	-224,891 Reduced 10.24%	1,972,343 $2.31 Million
Q1 2024 Oct 17, 2024	BUY	$1.48 - $1.99 $332,838 - $447,533	224,891 Added 11.4%	2,197,234 $3.8 Million
Q1 2024 Aug 16, 2024	SELL	$1.48 - $1.99 $124,983 - $168,051	-84,448 Reduced 3.7%	2,197,234 $3.8 Million
Q1 2024 May 15, 2024	SELL	$1.48 - $1.99 $124,983 - $168,051	-84,448 Reduced 3.7%	2,197,234 $3.8 Million
Q4 2023 Aug 16, 2024	BUY	$0.84 - $1.95 $259,844 - $603,211	309,339 Added 15.68%	2,281,682 $4.29 Million
Q4 2023 Feb 13, 2024	BUY	$0.84 - $1.95 $1.86 Million - $4.32 Million	2,212,869 Added 3215.77%	2,281,682 $4.29 Million
Q3 2023 Nov 15, 2023	SELL	$1.28 - $2.03 $172 - $274	-135 Reduced 0.2%	68,813 $97,000
Q2 2023 Aug 14, 2023	BUY	$1.61 - $2.19 $41,462 - $56,399	25,753 Added 59.62%	68,948 $135,000
Q1 2023 May 15, 2023	BUY	$1.88 - $2.98 $26,573 - $42,122	14,135 Added 48.64%	43,195 $81,000
Q4 2022 Feb 14, 2023	BUY	$2.22 - $3.1 $15,540 - $21,700	7,000 Added 31.73%	29,060 $66,000
Q3 2022 Nov 14, 2022	SELL	$2.51 - $4.85 $5,142 - $9,937	-2,049 Reduced 8.5%	22,060 $60,000
Q2 2022 Oct 27, 2022	BUY	$3.79 - $8.38 $28,887 - $63,872	7,622 Added 46.23%	24,109 $113,000
Q2 2022 Aug 15, 2022	BUY	$3.79 - $8.38 $28,887 - $63,872	7,622 Added 46.23%	24,109 $113,000
Q1 2022 Oct 27, 2022	SELL	$3.73 - $8.74 $28,430 - $66,616	-7,622 Reduced 31.61%	16,487 $87,000
Q1 2022 May 13, 2022	BUY	$3.73 - $8.74 $28,083 - $65,803	7,529 Added 84.05%	16,487 $87,000
Q4 2021 Feb 14, 2022	BUY	$6.4 - $15.65 $57,331 - $140,192	8,958 New	8,958 $57,000

Others Institutions Holding IOBT

# of Institutions

Shares Held

23.6M

Call Options Held

Put Options Held

View Full List

About IO Biotech, Inc.

Ticker IOBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,815,300
Market Cap $27.1M
Description
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...

More about IOBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account